ProfileGDS4132 / 216456_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 31% 33% 29% 28% 27% 30% 31% 27% 29% 31% 38% 36% 33% 38% 31% 36% 39% 31% 32% 39% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10177.085231
GSM201543Muscle PCOS pioglitazone 12173.20233
GSM201544Muscle PCOS pioglitazone 16174.646629
GSM201545Muscle PCOS pioglitazone 20175.655828
GSM201829Muscle PCOS pioglitazone 23168.833227
GSM201830Muscle PCOS pioglitazon 25175.533130
GSM201831Muscle PCOS pioglitazone 27175.938631
GSM201832Muscle PCOS pioglitazone 3165.942927
GSM201833Muscle PCOS pioglitazone 4166.558629
GSM201834Muscle PCOS pioglitazone 8173.144731
GSM201835Muscle PCOS after pioglitazone 10284.116338
GSM201836Muscle PCOS after pioglitazone 12280.331736
GSM201837Muscle PCOS after pioglitazone 16268.269833
GSM201838Muscle PCOS after pioglitazone 20286.420338
GSM201839Muscle PCOS after pioglitazone 23269.003631
GSM201840Muscle PCOS after pioglitazone 25287.841736
GSM201841Muscle PCOS after pioglitazone 27283.80739
GSM201842Muscle PCOS after pioglitazone 3259.842531
GSM201843Muscle PCOS after pioglitazone 4277.719932
GSM201844Muscle PCOS after pioglitazone 8294.910239